ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 164 filers reported holding ARGENX SE in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $424,000 | -9.0% | 1,540 | -2.8% | 0.23% | -20.1% |
| Q4 2020 | $466,000 | +8.9% | 1,584 | -2.8% | 0.28% | -2.4% |
| Q3 2020 | $428,000 | +16.6% | 1,630 | +0.1% | 0.29% | +8.2% |
| Q2 2020 | $367,000 | +82.6% | 1,628 | +6.6% | 0.27% | +32.7% |
| Q1 2020 | $201,000 | -15.9% | 1,527 | +2.6% | 0.20% | +9.8% |
| Q4 2019 | $239,000 | +11.2% | 1,488 | -2.0% | 0.18% | +5.7% |
| Q2 2019 | $215,000 | – | 1,518 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |